HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arora, T. Articles by Jelinek, D. F. Search for Related Content PubMed PubMed Citation Articles by Arora, T. Articles by Jelinek, D. F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Dissociation Between IFN--Induced Anti-Viral and Growth Signaling Pathways¹

Taruna Arora^*, Georgia Floyd-Smith, Mark J. Espy and Diane F. Jelinek^2,*

Departments of ^* Immunology and Microbiology, Mayo Clinic, Rochester, MN 55905; and Department of Biology and Molecular and Cellular Biology Program, Arizona State University, Tempe, AZ 85287

The ability of IFN- to induce an anti-viral state in a wide variety of cell types as well as to inhibit cellular growth has long been appreciated. It is less clear, however, whether both these effects lie downstream of a common signaling pathway. In this study we have taken advantage of an atypical human myeloma cell line (KAS-6/1) displaying a dramatic proliferative response to IFN- in an effort to resolve the signaling requirements for IFN--induced anti-viral and growth regulatory effects. Thus, we have analyzed the ability of IFN- to induce a number of known receptor-initiated events in this cell line and have compared these responses with those exhibited by a cell lineage- and maturation stage-matched myeloma cell line (ANBL-6) that displays typical IFN- responsiveness. Despite the widely contrasting effects of IFN- on cellular proliferation, IFN- was shown to be comparable in its ability to induce the expression of early response genes as well as induce resistance to viral infection in both cell lines. By contrast, the effects of IFN- on the activation of mitogen-activated protein kinase (MAPK) were strikingly distinct. Finally, although inhibition of MEK and MAPK activation had no effect on the induction of the anti-viral response, it completely blocked IFN--stimulated proliferation of the KAS-6/1 cells. In summary, our analysis of the role of the MAPK and anti-viral signaling pathways using these two cell lines suggests that the anti-viral and growth regulatory effects of IFN- display a differential requirement for activation of the MAPK pathway.

This article has been cited by other articles:

				N. Di Girolamo, D. Wakefield, and M. T. Coroneo UVB-Mediated Induction of Cytokines and Growth Factors in Pterygium Epithelial Cells Involves Cell Surface Receptors and Intracellular Signaling. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2430 - 2437. [Abstract] [Full Text] [PDF]

				L. H. Shorts, C. E. Dancz, J. W. Shupp, and C. H. Pontzer Characterization of N-Terminal Interferon {tau} Mutants: P26L Affords Enhanced Activity and Lack of Toxicity Experimental Biology and Medicine, February 1, 2004; 229(2): 194 - 202. [Abstract] [Full Text] [PDF]

				D. Gomez and N. C. Reich Stimulation of Primary Human Endothelial Cell Proliferation by IFN J. Immunol., June 1, 2003; 170(11): 5373 - 5381. [Abstract] [Full Text] [PDF]

				V. S. Cull, P. A. Tilbrook, E. J. Bartlett, N. L. Brekalo, and C. M. James Type I interferon differential therapy for erythroleukemia: specificity of STAT activation Blood, April 1, 2003; 101(7): 2727 - 2735. [Abstract] [Full Text] [PDF]

				P. Harle, V. Cull, M.-P. Agbaga, R. Silverman, B. R. G. Williams, C. James, and D. J. J. Carr Differential Effect of Murine Alpha/Beta Interferon Transgenes on Antagonization of Herpes Simplex Virus Type 1 Replication J. Virol., June 5, 2002; 76(13): 6558 - 6567. [Abstract] [Full Text] [PDF]

				D. L. Brassard, M. J. Grace, and R. W. Bordens Interferon-{alpha} as an immunotherapeutic protein J. Leukoc. Biol., April 1, 2002; 71(4): 565 - 581. [Abstract] [Full Text] [PDF]

				R. Gongora, R. P. Stephan, R. D. Schreiber, and M. D. Cooper Stat-1 Is Not Essential for Inhibition of B Lymphopoiesis by Type I IFNs J. Immunol., September 1, 2000; 165(5): 2362 - 2366. [Abstract] [Full Text] [PDF]

				D. Zella, F. Romerio, S. Curreli, P. Secchiero, C. Cicala, D. Zagury, and R. C. Gallo IFN-{alpha}2b Reduces IL-2 Production and IL-2 Receptor Function in Primary CD4+ T Cells J. Immunol., March 1, 2000; 164(5): 2296 - 2302. [Abstract] [Full Text] [PDF]

				E. Pattyn, X. Van Ostade, L. Schauvliege, A. Verhee, M. Kalai, J. Vandekerckhove, and J. Tavernier Dimerization of the Interferon Type I Receptor IFNaR2-2 Is Sufficient for Induction of Interferon Effector Genes but Not for Full Antiviral Activity J. Biol. Chem., December 3, 1999; 274(49): 34838 - 34845. [Abstract] [Full Text] [PDF]